Discarded — an endpoint this vocabulary does not hold4 papers
PMID:40148550no claim extracted — no_outcome_node — measured: offspring neurodevelopmental disorder / ADHD / ASD incidence following in utero methylphenidate exposure, adjusted hazard ratio | any neurodevelopmental disorder diagnosis (including ADHD and ASD) after in utero ADHD medication exposure, ascertained via national patient register diagnosis or medication dispensation, Cox proportional hazards HRpipeline:batch2026-09-29
PMID:30928951no claim extracted — no_outcome_node — measured: teacher-rated ADHD symptoms, methylphenidate versus placebo or no-treatment, compared between parallel and crossover randomised trial designs | teacher-rated ADHD symptoms scorepipeline:batch2026-09-29
PMID:31090281no claim extracted — no_outcome_node — measured: methylphenidate-associated sleep-related adverse events (insomnia general, initial insomnia, middle insomnia, combined insomnia, sleep disorder), pooled relative risk from blinded placebo-controlled studies | sleep-related adverse events, pooled relative riskpipeline:batch2026-09-29
Discarded — another reason, stated per paper3 papers
PMID:34797323no claim extracted — cause not determined (one pass only) — measured: methylphenidate treatment response in children with ADHD, pooled across candidate-gene pharmacogenomic studiespipeline:batch2026-09-29
PMID:39504019no claim extracted — cause not determined (one pass only) — measured: congenital anomaly / miscarriage incidence following in utero methylphenidate or atomoxetine exposure, pooled odds ratiopipeline:batch2026-09-29
PMID:31221690no claim extracted — cause not determined (one pass only) — measured: ADHD core symptoms, pooled SMDpipeline:batch2026-09-29
Discarded — no extractable result2 papers
PMID:31685858claims extracted but the two passes did not agreepipeline:batch2026-09-29
PMID:29744873claims extracted but refused by the deterministic validatorspipeline:batch2026-09-29